Nature Medicine, suggests directions for the development of future therapeutics that may be more resistant to mutations of SARS-CoV-2.Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more advice on prevention and treatment.A central focus of scientific research in response to the COVID-19 pandemic has been the development of vaccines.However, scientists have also been looking at other therapeutics that may be effective in reducing transmission of the virus or decreasing the severity of its symptoms.One such technology is monoclonal antibodies.
According to the Food and Drug Administration (FDA), monoclonal antibodies are developed in a laboratory and designed to copy the function of a.